Author:
Chakrabarty Arindam C,Bennett Jeffrey I,Baloch Talha J,Shah Rohit P,Hawk Cassie,Natof Tyler
Publisher
Springer Science and Business Media LLC
Reference12 articles.
1. Antipsychotic-induced tardive dyskinesia: update on epidemiology and management;Widschwendter CG;Curr Opin Psychiatry,2019
2. Tardive dyskinesia prevalence in the period of second-generation antipsychotic use: a meta-analysis;Carbon M;J Clin Psychiatry,2017
3. Revisiting the abnormal involuntary movement scale: proceedings from the tardive dyskinesia assessment workshop;Kane JM;J Clin Psychiatry,2018
4. Full prescribing information - Ingrezza. (2021). Accessed. March 23, 2023: https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209241s020lbl.pdf.
5. Full prescribing information - Austedo (deutetrabenazine) tablets, for oral use. (2017). Accessed. March 23, 2023: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208082s000lbl.pdf.